Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 226 results We respond to the announcement of more than £25m being invested in diagnostic equipment for NHS Wales 03 Jun 2021 1 min read We respond to government funding announcement for early career researchers supported by charities 08 Jun 2021 1 min read We respond to a new clinical trial into olaparib use for women with high risk HER2 negative primary breast cancer with altered BRCA genes 08 Jun 2021 1 min read We respond to new figures from Cancer Research UK showing thousands fewer breast cancer patients started treatment in the last year in England 15 Jun 2021 1 min read We respond to POLQ inhibitors identified as a new class of targeted drugs for cancers with BRCA mutations 17 Jun 2021 1 min read We respond to new research into fertility drugs and breast cancer risk 21 Jun 2021 1 min read We respond to NHS England breast cancer waiting times: May 2021 08 Jul 2021 3 min read We respond to ‘plasmaMATCH’ trial that uses blood test to match women with breast cancer to a range of precision treatments 11 Sept 2020 1 min read We welcome SMC approval of adjuvant Kadcyla and atezolizumab with nab-paclitaxel for use on the NHS 09 Nov 2020 3 min read We support recommendations for faster and wider access to innovative cancer treatments 09 Nov 2020 1 min read We respond to news that the pandemic ‘threatens research as early career scientists look to leave’ 10 Nov 2020 1 min read We respond to a BMJ Study that provides new estimates of breast cancer risks associated with HRT 10 Nov 2020 1 min read Previous 1 ... 18 19 Next
We respond to the announcement of more than £25m being invested in diagnostic equipment for NHS Wales 03 Jun 2021 1 min read
We respond to government funding announcement for early career researchers supported by charities 08 Jun 2021 1 min read
We respond to a new clinical trial into olaparib use for women with high risk HER2 negative primary breast cancer with altered BRCA genes 08 Jun 2021 1 min read
We respond to new figures from Cancer Research UK showing thousands fewer breast cancer patients started treatment in the last year in England 15 Jun 2021 1 min read
We respond to POLQ inhibitors identified as a new class of targeted drugs for cancers with BRCA mutations 17 Jun 2021 1 min read
We respond to ‘plasmaMATCH’ trial that uses blood test to match women with breast cancer to a range of precision treatments 11 Sept 2020 1 min read
We welcome SMC approval of adjuvant Kadcyla and atezolizumab with nab-paclitaxel for use on the NHS 09 Nov 2020 3 min read
We support recommendations for faster and wider access to innovative cancer treatments 09 Nov 2020 1 min read
We respond to news that the pandemic ‘threatens research as early career scientists look to leave’ 10 Nov 2020 1 min read
We respond to a BMJ Study that provides new estimates of breast cancer risks associated with HRT 10 Nov 2020 1 min read
